 Breast Neoplasms
"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
| Descriptor ID |
D001943
|
| MeSH Number(s) |
C04.588.180 C17.800.090.500
|
| Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Neoplasms, Breast
- Tumors, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Mammary Carcinoma, Human- Mammary Carcinoma, Human
- Carcinoma, Human Mammary
- Carcinomas, Human Mammary
- Human Mammary Carcinomas
- Mammary Carcinomas, Human
- Human Mammary Carcinoma
Breast Cancer- Breast Cancer
- Cancer, Breast
- Cancer of Breast
- Mammary Cancer
- Malignant Neoplasm of Breast
- Malignant Tumor of Breast
- Breast Carcinoma
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 2 | 0 | 2 | | 1981 | 2 | 0 | 2 | | 1983 | 2 | 0 | 2 | | 1984 | 1 | 0 | 1 | | 1985 | 3 | 0 | 3 | | 1986 | 3 | 0 | 3 | | 1987 | 2 | 0 | 2 | | 1988 | 4 | 0 | 4 | | 1989 | 1 | 1 | 2 | | 1990 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 5 | 0 | 5 | | 1994 | 6 | 0 | 6 | | 1995 | 5 | 1 | 6 | | 1996 | 4 | 1 | 5 | | 1997 | 2 | 0 | 2 | | 1998 | 4 | 4 | 8 | | 1999 | 2 | 4 | 6 | | 2000 | 2 | 1 | 3 | | 2001 | 5 | 2 | 7 | | 2002 | 10 | 2 | 12 | | 2003 | 6 | 2 | 8 | | 2004 | 15 | 3 | 18 | | 2005 | 18 | 1 | 19 | | 2006 | 10 | 0 | 10 | | 2007 | 22 | 1 | 23 | | 2008 | 14 | 2 | 16 | | 2009 | 13 | 1 | 14 | | 2010 | 14 | 3 | 17 | | 2011 | 9 | 1 | 10 | | 2012 | 6 | 1 | 7 | | 2013 | 11 | 2 | 13 | | 2014 | 12 | 1 | 13 | | 2015 | 5 | 5 | 10 | | 2016 | 13 | 1 | 14 | | 2017 | 13 | 6 | 19 | | 2018 | 12 | 1 | 13 | | 2019 | 19 | 0 | 19 | | 2020 | 8 | 2 | 10 | | 2021 | 14 | 0 | 14 | | 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Boni V, Fidler MJ, Arkenau HT, Spira A, Meric-Bernstam F, Uboha N, Sanborn RE, Sweis RF, LoRusso P, Nagasaka M, Garcia-Corbacho J, Jalal S, Harding JJ, Kim SK, Miedema IHC, Vugts DJ, Huisman MC, Zwezerijnen GJC, van Dongen GAMS, Menke van der Houven van Oordt CW, Wang S, Dang T, Zein IA, Vasiljeva O, Lyman SK, Paton V, Hannah A, Liu JF. Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clin Cancer Res. 2022 05 13; 28(10):2020-2029.
-
Ma CX, Luo J, Freedman RA, Pluard TJ, Nangia JR, Lu J, Valdez-Albini F, Cobleigh M, Jones JM, Lin NU, Winer EP, Marcom PK, Thomas S, Anderson J, Haas B, Bucheit L, Bryce R, Lalani AS, Carey LA, Goetz MP, Gao F, Kimmick G, Pegram MD, Ellis MJ, Bose R. The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer. Clin Cancer Res. 2022 04 01; 28(7):1258-1267.
-
Usha L, Klapko O, Edassery S. Xenogeneic fibroblasts inhibit the growth of the breast and ovarian cancer cell lines in co-culture. Neoplasma. 2021 Nov; 68(6):1265-1271.
-
Yun NK, Slostad JA, Naqib A, Frankenberger C, Perez CB, Ghai R, Usha L. Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics. Oncologist. 2021 12; 26(12):1000-1005.
-
Duan L, Calhoun S, Shim D, Perez RE, Blatter LA, Maki CG. Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells. J Mol Cell Biol. 2021 09 11; 13(6):433-444.
-
Deliere A, Attai D, Victorson D, Kuchta K, Pesce C, Kopkash K, Sisco M, Seth A, Yao K. Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study. Ann Surg Oncol. 2021 Oct; 28(10):5686-5697.
-
Blazek A, O'Donoghue C, Terranella S, Ritz E, Alvarado R, Perez C, Madrigrano A. Impact of Inequities on Delay in Breast Cancer Management in Women Undergoing Second Opinions. J Surg Res. 2021 12; 268:445-451.
-
Sheean P, Gomez-Perez S, Joyce C, O'Connor P, Bojko M, Smith A, Vasilopoulos V, Rao R, Sclamberg J, Robinson P. Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer. Breast Cancer Res Treat. 2021 Nov; 190(1):121-132.
-
Grunvald MW, Williams MD, Rao RD, O'Donoghue CM, Becerra AZ. 100 Disruptive Publications in Breast Cancer Research. Asian Pac J Cancer Prev. 2021 Aug 01; 22(8):2385-2389.
-
Kopkash K, Novak K, Murphy R, Deliere A, Kuchta K, Rabbitt S, Pesce C, Winchester D, Yao K. Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and Operating Room Positioning Protocol. Ann Surg Oncol. 2021 Oct; 28(10):5698-5706.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|